Biogen Idec

NASDAQ: BIIB
$278.88
+$0.18 (+0.1%)
Closing price July 10, 2020
Biogen may be on track to be one of the first companies with a meaningful treatment for Alzheimer’s disease, and this could have huge implications for the stock.
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Monday's top analyst upgrades and downgrades included American Express, Biogen, Discover Financial, DraftKings, Ericsson, Foot Locker, Gap, Kraft Heinz, Nikola, Walmart and Zscaler.
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Thursday's top analyst upgrades and downgrades included Apple, AT&T, Avis Budget, Baidu, Baker Hughes, Biogen, Chipotle Mexican Grill, Kinder Morgan, Netflix, Shopify and Ulta Beauty.
Biogen reported better than expected first-quarter financial results before the markets opened on Wednesday.
24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including Amazon, Tesla, Netflix and Starbucks.
The March 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks shrank.
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.